Introduction
Oxidative stress is defined as an imbalance between high reactive oxygen species and cellular antioxidant defense (Yatin et al., 2000; Nazıroğlu, 2007) . In order to scavenge reactive oxygen species, various defense systems exist in the brain. Levels of the antioxidants in the cerebral cortex are considerable low. Therefore, low level of antioxidant and high content of polyunsaturated fatty acids result in limited antioxidant defense in the brain (Cherubini et al., 2008; Nazıroğlu, 2011) . Glutathione peroxidase, a selenium containing enzyme, is responsible for the reduction of hydro and organic peroxides in the brain (Nazıroğlu and Yürekli, 2013) . Reduced glutathione is a hydroxyl radical and singlet oxygen scavenger that participates in a wide range of cellular functions Senol et al., 2014) . Vitamin E, alpha-tocopherol, is the most important antioxidant in the lipid phase of cells (Nazıroğlu, 2007) . Vitamin C, ascorbic acid, as a free radical scavenger, also transforms vitamin E to its active form (Cherubini et al., 2008; Nazıroğlu, 2011) . Vitamin A, retinol, serves as a prohormone for retinoids and is involved in signal transduction at cytoplasmic and membrane sites (Cherubini et al., 2008; Nazıroğlu, 2011) . Traumatic brain injury is one of the most common causes of the mortalities (Cornelius et al., 2013) . Secondary events occur after primary events like shearing of nerve cells and blood vessels, cause post-traumatic neurodegenerations with an increase in reactive oxygen species and reactive oxygen species-mediated lipid peroxidation (Cornelius et al., 2013) . Three different types of metabolic disturbances occur after traumatic brain injury: inflammation, ischemia and calcium ion entry (Campolo et al., 2013) . Ischemia/reperfusion negatively influence outcome as oxygen and glucose deprivation reduces cerebral oxidative metabolism. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a major complex that produces reactive oxygen species during the ischemic period (Niesman et al., 2014) . Concurrently with these metabolic disturbances, also after traumatic brain injury, several factors like extravagated blood products, tissue debris, intracellular components, prostaglandins, reactive oxygen-nitrogen species trigger inflammation (Cornelius et al., 2013) . Once blood-brain barrier is disrupted, neutrophils, monocytes, and lymphocytes accumulate in the injured brain area, and microglia are activated by Ca 2+ entry, all these initiate inflammatory response (Esposito and Cuzzocrea, 2010) . Leucocytes release cytokines, proteases, prostaglandins, and free oxygen-nitrogen species (Kayan et al., 2012) .
Melatonin, a hormone secreted from pineal gland and synthesized from tryptophan or formed as the metabolic end product of serotonin, is a non-enzymatic antioxidant and neuroprotective agent (Espino et al., 2012; Nazıroğlu et al., 2012b) . As an antioxidant, melatonin scavenges the free radicals and/or stimulates the enzymes of antioxidant defense system (Reiter et al., 1997) . The efficacy of melatonin for post-traumatic brain injury has been shown in in vivo and in vitro studies (Esposito and Cuzzocrea, 2010; Campolo et al., 2013) . Melatonin has been shown to counteract oxidative stress-induced pathophysiologic conditions like cerebral ischemia/reperfusion injury, neuronal excitotoxicity and chronic inflammation (Reiter et al., 1997; Ekmekcioglu, 2006; Celik and Nazıroğlu, 2012; Espino et al., 2012; Nazıroğlu et al., 2012b) . We proposed the hypotheses that modulation of oxidative stress in blood and the cerebral cortex by means of treatment with melatonin may cause an increase in antioxidant vitamin level.
Hence, we aimed to evaluate whether there would be a protective effect of melatonin on oxidative stress and enzymatic and non-enzymatic antioxidant levels in traumatic brain injury rats.
Materials and Methods
Animals Thirty-two 6-month-old male Sprague-Dawley rats, weighing 350 ± 20 g, were used for the experimental procedures. The ambient temperature and relative humidity of the animal room were 21 ± 1°C and 60 ± 7%, respectively. The room was illuminated with artificial light for a 12-hour dark/ light cycle. The animals were allowed free access to standard pelleted food and tap water. All studies were performed with the approval of the ethical committee of Medical Faculty of Suleyman Demirel University (Protocol No. 2013/2-1).
Experimental design
Thirty-two rats were randomly and evenly divided into four groups as follows: Control group (n = 8): Placebo (0.1 mL ethanol + 0.9 mL isotonic saline) was intraperitoneally given to the rats. Melatonin group (n = 8): Only melatonin (10 mg/kg body weight) was intraperitoneally given to rats at 1 hour after brain trauma (Dilek et al., 2010) . Melatonin was obtained from Sigma Chemical Co. (Istanbul, Turkey). Traumatic brain injury group (n = 8): a contusional head trauma model was established (Marmarou et al., 1994; Senol et al., 2014) . Traumatic brain injury + melatonin group (n = 8): Melatonin (5 mg/kg body weight) was intraperitoneally administrated to rats at 1 hour after brain trauma. At 24 hours after melatonin administration, rats were sacrificed, and the cerebral cortex and blood samples were taken. Melatonin was dissolved in ethanol (0.1 mL) and diluted with 0.9 mL isotonic saline (0.9%, v/w) before use.
Induction of traumatic brain injury
Marmarou method (Marmarou et al., 1994; Senol et al., 2014) was used to make a diffuse head trauma. Rats were anesthetized with a cocktail of ketamine hydrochloride (80 mg/kg) and xylazine (10 mg/kg) administered intraperitoneally before induction of traumatic brain injury. The animals were placed in the prone position on the trauma table under anesthesia. After skin incision, a steel disc (10 mm × 3 mm) was placed on the midline between coronal and lambdoid sutures on the animal's skull, and a 300 g weight was freely dropped through a cylindrical tube, with 19 mm inner diameter, from 2 m height onto the head of the animal.
Anesthesia and preparation of the cerebral cortex and blood samples
Following anesthesia with ether, rats were sacrificed and the cerebral cortex and blood samples were taken. Then the cerebral cortex was processed as follows: the cortex was dissected out after the brain was split in the mid-sagittal plane as described in our previous study . Cerebral cortex tissues were washed twice with cold saline solution, placed into glass bottles, labeled and stored at -85°C until processing (maximum 4 weeks). After weighing, half of the cortex was placed on ice, cut into small pieces, using scissors, and homogenized (2 minutes at 3,000 × g) in a 5-fold volume (1:5, w/v) of ice-cold Tris-HCl buffer (50 mmol/L, pH 7.4), by using an ultrasonic homogenizer (Bandelin-2070, BANDELIN electronic, GmbH & Co. KG, Berlin, Germany). All preparation procedures were performed on ice. The blood (2-4 mL) was taken from the heart, using a sterile injector, and contained in anticoagulant (EDTA) coated vacutainer tube for protecting against light. Blood sample was separated into plasma and erythrocytes by centrifugation at 1,500 × g for 10 minutes at 4°C. The erythrocyte samples were washed three times in cold isotonic saline (0.9%, v/ w), then hemolyzed with a 9-fold volume of phosphate buffer (50 mmol/L, pH 7.4). After addition of butylhydroxytoluol (4 μL per mL), the brain homogenate, hemolyzed erythrocytes and plasma samples were stored at -80°C for no more than 4 weeks for measurement of enzymatic activity. The remaining brain tissue homogenate, hemolyzed erythrocytes and plasma samples were used for immediate lipid peroxidation and vitamin assay.
Lipid peroxidation level determinations
Lipid peroxidation levels in the brain tissue homogenate, hemolyzed erythrocytes and plasma samples were assayed for production of lipid peroxidation by monitoring production of thiobarbituric-acid reactive substances as described previously (Placer et al., 1966) . The levels of lipid peroxidation in the brain tissue homogenate, hemolyzed erythrocytes and plasma samples were expressed as μmol/ g protein and μmol/L, respectively.
Glutathione, glutathione peroxidase and protein assay
The reduced glutathione content in the cerebral cortex and erythrocytes was measured at 412 nm using the method of Sedlak and Lindsay (1968) as described in own previous studies (Dilek et al., 2010; Nazıroğlu et al., 2012a) . Glutathione peroxidase activities of cerebral cortex and erythrocytes were measured spectrophotometrically (Shimadzu UV-1800, Shimadzu Corp., Kyoto, Japan) at 37 °C and 412 nm according to the Lawrence and Burk (Lawrence and Burk, 1976) . The protein content in the cerebral cortex and erythrocytes was measured by method of Lowry et al. (1951) with bovine serum albumin as the standard.
Determination of β-carotene, vitamin A, vitamin C and vitamin E in the cerebral cortex
Vitamins A (retinol) and E (α-tocopherol) were determined in the cerebral cortex samples by a modification of the method described by Desai (1984) and Suzuki and Katoh (1990) . Approximately 0.25 g brain tissue and 0.25 mL plasma sample was saponified by adding 0.3 mL 60% (w/v in water) KOH and 2 mL 1% (w/v in ethanol) ascorbic acid, followed by heating at 70°C for 30 minutes. After cooling the samples on ice, 2 mL water and 1 mL n-hexane were added to the samples, mixed, and allowed to stand for 10 minutes for phase separation. A 0.5-mL n-hexane extract aliquot was taken, and the vitamin A level was spectrophotometrically (Shimadzu UV-1800, Shimadzu Corp., Kyoto, Japan) measured at 325 nm. Next, reactants were added, and the hexane absorbance value was measured at 535 nm in the spectrophotometer. Calibrations were performed using standard solutions of all-trans retinol and α-tocopherol in hexane. The β-carotene level in the cerebral cortex was determined as described previously (Suzuki and Katoh, 1990) . We mixed 2 mL hexane with 0.25 g brain tissue and 0.25 mL plasma. The β-carotene level in the hexane mixture was measured at 453 nm using the spectrophotometer.
Quantification of vitamin C (ascorbic acid) in the plasma and cerebral cortex samples was performed according to the method of Jagota and Dani (Jagota and Dani, 1982) . The absorbance of the samples was measured spectrophotometrically (Shimadzu UV-1800, Shimadzu Corp., Kyoto, Japan) at 760 nm.
Statistical analysis
All data are expressed as mean ± standard deviation (SD). P-values < 0.05 were regarded as statistically significant. Significant values were assessed with the Mann-Whitney U test. Data were analyzed using the SPSS statistical program (version 17.0 software, SPSS, Chicago, IL, USA).
Results

Lipid peroxidation levels
The cerebral cortex, plasma and erythrocyte lipid peroxidation levels in four groups are shown in Tables 1-3. Lipid peroxidation levels in the cerebral cortex, plasma and erythrocytes in the traumatic brain injury group were significantly (P < 0.05) higher than in the control group. The cerebral cortex (P < 0.05), plasma (P < 0.01) and erythrocyte (P < 0.01) lipid peroxidation levels in the traumatic brain injury + melatonin group were significantly lower than in the traumatic brain injury group, respectively.
Glutathione peroxidase activity and reduced glutathione level
The cerebral cortex glutathione peroxidase activity was significantly (P < 0.05) lower in the traumatic brain injury group as compared to control and traumatic brain injury + melatonin groups although its activity did not differ between traumatic brain injury and traumatic brain injury + melatonin groups. Hence, the glutathione peroxidase activity was increased by melatonin administration ( Table 1) . There was no statistical change in the glutathione peroxidase activity in erythrocyte sample among the four groups (Table 3) . Re- The data are expressed as mean ± SD of eight rats from each group. *P < 0.05, **P < 0.01, ***P < 0.001, vs. control and melatonin groups. #P < 0.05, ###P < 0.001, vs. TBI group. Significant values were assessed with the Mann-Whitney U test. The data are expressed as mean ± SD of eight rats from each group. *P < 0.05, vs. control and melatonin groups. ##P < 0.01 and ###P < 0.001, vs. TBI group. Significant values were assessed with the Mann-Whitney U test. The data are expressed as mean ± SD of eight rats from each group. *P < 0.05, **P < 0.01, vs. control and melatonin groups. ##P < 0.01 and ###P < 0.001, vs. TBI group. Significant values were assessed with the Mann-Whitney U test.
Table 1 The effects of melatonin on glutathione peroxidase (GSH-Px), reduced glutathione (GSH), lipid peroxidation (LP), vitamin A, vitamin C, vitamin E and β-carotene values in the cerebral cortex traumatic brain injury (TBI)-induced rats
Table 3 The effects of melatonin on erythrocyte glutathione peroxidase (GSH-Px) activity, reduced glutathione (GSH) and lipid peroxidation (LP) levels in traumatic brain injury (TBI)-induced rats
duced glutathione level in the cerebral cortex (P < 0.01) and erythrocyte samples (P < 0.05) were significantly decreased in the traumatic brain injury groups than in the control and traumatic brain injury + melatonin groups. The decreased reduced glutathione levels in the cerebral cortex and erythrocyte samples were increased by melatonin administration ( Table 1) . On the other word, the erythrocyte reduced glutathione level in the traumatic brain injury + melatonin group was significantly (P < 0.001) higher than in the traumatic brain injury group (Table 3) .
Antioxidant vitamin levels
The β-carotene, vitamin C, and vitamin E levels in the cerebral cortex and plasma samples of four groups are shown in Tables 1 and 2, respectively. The vitamin A and vitamin E levels in the cerebral cortex and plasma samples were not affected by melatonin and traumatic brain injury. The β-carotene (P < 0.001), vitamin C (P < 0.001) and vitamin E (P < 0.05) levels in the cerebral cortex were significantly lower in the traumatic brain injury group as compared to the control and melatonin groups. Cerebral cortex β-carotene and vitamin C levels and plasma vitamin C level were significantly increased (P < 0.001) following melatonin administration.
Discussion
Results from this study demonstrated that the cerebral cortex, plasma and erythrocyte lipid peroxidation levels were increased by traumatic brain injury induction although cerebral cortex and erythrocyte reduced glutathione, cerebral cortex glutathione peroxidase, cerebral cortex vitamin C, vitamin E, and β-carotene levels were decreased by the induction of traumatic brain injury. Traumatic brain injury induction in the animals is characterized by an increase in lipid peroxidation and decreases in glutathione peroxidase, β-carotene and vitamin C and vitamin E antioxidant levels. Administration of melatonin caused a decrease in the cerebral cortex, plasma and erythrocyte lipid peroxidation levels although reduced glutathione, β-carotene, vitamin C and vitamin E levels increased. A limited number of in vivo or in vitro studies in tissues except the brain of experimental animals have been reported regarding the effects of melatonin on antioxidant enzymatic system and lipid peroxidation levels (Kerman et al., 2005; Ozdemir et al., 2005; Lee et al., 2009; Fernández-Gajardo et al., 2014) . To the best of our knowledge, the current study is the first to compare the medicine with particular reference to its effects on oxidative stress and antioxidant redox system in the blood and cerebral cortex of traumatic brain injury-induced rats. It is well known that the production of lipid peroxidation (malonaldehyde) as the end product of lipid peroxidation is a major indicator of oxidative brain injury. Results of recent studies indicated that lipid peroxidation has been linked to microvascular damage and ischemia/reperfusion injury which, is severe enough, can lead to overproduction of oxidative stress. In addition, inflammation is closely related to the overproduction of reactive oxygen species and plays an important role in various brain injuries. Melatonin, as an antioxidant, is one of the drugs that are studied for traumatic brain injury and it, as a free radical scavenger, protects against free radical formation (Reiter et al., 1997; Espino et al., 2012; Nazıroğlu et al., 2012) . It has also been reported that melatonin stimulates various antioxidants such as reduced glutathione and glutathione peroxidase that contribute to the antioxidant defense system, and suppresses lipid peroxidation by preventing traumatic brain injury-mediated neurotoxicity (Martín et al., 2000) . Lee et al. (2009) had studied the neuroprotective effect of melatonin on oxidative stress after surgical brain injury in rats and they reported its beneficial effect on neurological oxidative stress. Seifman et al. (2014) reported that endogenous melatonin decreased oxidative stress in cerebrospinal fluid of patients after severe traumatic brain injury and correlated with oxidative stress and metabolic disarray. To the best of our knowledge, there is no report on the modulatory role of melatonin on antioxidant vitamins in animals and human with traumatic brain injury. We firstly detected significant decreases in lipid peroxidation levels in the cerebral cortex, plasma and erythrocyte samples of traumatic brain injury-induced rats by melatonin treatment although reduced glutathione, glutathione peroxidase, vitamin C, vitamin E and β-carotene levels were increased by melatonin treatment. Thus, melatonin with antioxidant and anti-inflammatory properties are proposed to be useful in brain oxidative damage induced by traumatic brain injury.
Inactivation of reactive oxygen species can be carried out by antioxidant vitamins. Vitamin E, alpha-tocopherol, is the most important antioxidant in the lipid phase of cells. Vitamin E acts to protect cells against the effects of free radicals, which are potentially damaging byproducts of the body's metabolism (Nazıroğlu and Özgül, 2013) . Vitamin C, as well as being a water soluble reactive oxygen species scavenger, also transforms vitamin E to its active form (Bowman, 2012) . Levels of the antioxidants in the brain are considerable low. Therefore, low level of antioxidants and high content of PUFA, result in limited antioxidant defense in the cerebral cortex (Nazıroğ-lu, 2012; . Vitamin C, vitamin E and β-carotene levels in the cerebral cortex were decreased in the traumatic brain injury group although their levels in the cerebral cortex were increased in the melatonin-treated groups. The increased levels of the antioxidant vitamins could be due to thier depletion or inhibition as a result of the increased production of free radicals. The increase in the cerebral cortex vitamin C, vitamin E and β-carotene levels in animals during melatonin treatments has been attributed to the inhibition of free radicals and lipid peroxidation (Tuzcu and Baydas, 2006; Dilek et al., 2010; Nazıroğlu et al., 2012) . Similarly, Ishaq et al. (2013) reported that traumatic brain injury caused a decrease in vitamins C and E levels in the blood and brain tissue of traumatic brain injury-induced rats.
Reduced glutathione is the predominant antioxidant in the cerebral cortex that is present in millimolar concentrations. Reduced glutathione homoeostasis is implicated in the etiology of a number of brain diseases including traumatic brain injury (Senol et al., 2014) . Melatonin is a ubiquitously acting direct reactive oxygen species scavenger and also an indirect antioxidant. It was reported that reduced glutathione level and brain glutathione peroxidase activity, the critical components of reduced glutathione-redox cycle, were significantly decreased in the experimentally induced traumatic brain injury (Martín et al., 2000; Esposito and Cuzzocrea, 2010; Campolo et al., 2013) . Results from the present study showed that traumatic brain injury induced significant decrease in lipid peroxidation in the cerebral cortex and blood samples, while melatonin treatment reversed these effects.
In conclusion, melatonin supplementation has protective effect on oxidative stress and antioxidant redox system in the cerebral cortex and blood. Melatonin can regulate reduced glutathione and antioxidant vitamins levels and glutathione peroxidase activity in the cerebral cortex. Hence, use of melatonin in traumatic brain injury may be a potential approach to arresting or inhibiting the oxidative stress caused by excitotoxic agents.
